Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MicroRNA-299-3p as a potential marker of tumor size in non-small cell lung cancer.

Turk gogus kalp damar cerrahisi dergisi·2026
Same author

Sensitivity, Specificity, and Accuracy of Ultrasound, Mammography, and <sup>18</sup>F-FDG PET/CT in Diagnosing Breast Cancer Metastasis to Axillary Lymph Nodes: A Single-Center Experience.

Medicina (Kaunas, Lithuania)·2026
Same author

Integrating large-scale serum metabolomics and <i>APOE</i> ε4 genotype status for the non-invasive detection of Alzheimer's disease in the ADNI cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Motivations for accepting or refusing Covid-19 vaccination in nursing homes and long-term care centers in France: the Vaccovid-senior study.

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same author

Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes.

Viruses·2025
Same author

Assessing the impact of sarcopenia on balance in the elderly: an analysis using a force platform.

BMC geriatrics·2025

相关实验视频

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

技术与痴呆症 会议前会议

Dany Mukesha1,2, Maite Sarter1, Mélitine Dubray1

  • 1Firalis, Huningue, France.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
概括

这项研究确定了关键的代谢生物标志物和APOE基因型,以区分阿尔茨海默病 (AD) 和患有勒维体痴呆症 (DLB). 这些发现提高了AD的诊断准确性,有助于更早,更精确的患者护理.

更多相关视频

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

相关实验视频

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 计算生物学 计算生物学

背景情况:

  • 由于症状重叠,阿尔茨海默氏症 (AD) 和患有勒维体痴呆症 (DLB) 之间的临床区分具有挑战性.
  • 错误诊断可能导致神经退行性疾病的治疗策略延迟或不正确.

研究的目的:

  • 用血清样本确定可靠的代谢生物标志物,以区分AD和DLB.
  • 评估机器学习模型与新陈代谢数据和APOE基因型定型相结合的实用性,以提高诊断准确度.

主要方法:

  • 针对使用LC-HR-MS的AD,DLB和健康对照 (HC) 个体的血清样本的向代谢分析.
  • 机器学习算法的应用 (Lasso,随机森林,XGBoost) 用于分类.
  • 包括APOE基因型数据以提高模型性能.

主要成果:

  • 与DLB和HC组相比,在AD患者中观察到APOE基因型 (e3/e4,e4/e4) 的显著差异.
  • 在各组中发现了明显的脂质调节失调模式,包括甲基胆和甲基胆.
  • 结合63种已识别的代谢物和APOE基因型定型,改善了AD与DLB分类的曲线下的面积 (AUC) 从0.78到0.81和AD与HC分类从0.78到0.83.

结论:

  • 代谢特征,特别是基于脂质的生物标志物,在区分AD和DLB方面表现有前途.
  • APOE基因型鉴定显著提高了阿尔茨海默病的分类准确性.
  • 需要在更大的队列中进一步验证,以开发一种非侵入性诊断工具,以减少误诊率.